文献

J-GLOBAL ID：202102229538819856   整理番号：21A0598132

腎移植後の結腸直腸癌患者におけるベバシズマブ+mFOLFOX6投与中の重度蛋白尿:症例報告

Severe proteinuria during the administration of bevacizumab plus mFOLFOX6 in a colorectal cancer patient after kidney transplantation: a case report

著者 (8件)： Onodera Ren (Department of Pharmacy, Iwate Medical University Hospital, Iwate, Japan) ,  Nihei Satoru (Department of Pharmacy, Iwate Medical University Hospital, Iwate, Japan) ,  Nihei Satoru (Department of Clinical Pharmaceutics and Pharmacy Practice, School of Pharmacy, Iwate Medical University, Iwate, Japan) ,  Kimura Toshimoto (Department of Surgery, School of Medicine, Iwate Medical University, Iwate, Japan) ,  Tomita Takashi (Department of Pharmacy, Iwate Medical University Hospital, Iwate, Japan) ,  Tomita Takashi (Department of Clinical Pharmaceutics and Pharmacy Practice, School of Pharmacy, Iwate Medical University, Iwate, Japan) ,  Kudo Kenzo (Department of Pharmacy, Iwate Medical University Hospital, Iwate, Japan) ,  Kudo Kenzo (Department of Clinical Pharmaceutics and Pharmacy Practice, School of Pharmacy, Iwate Medical University, Iwate, Japan)
資料名： Journal of Pharmaceutical Health Care and Sciences (Web)  (Journal of Pharmaceutical Health Care and Sciences (Web))
巻： 6  号： 1  ページ： 1-5  発行年： 2020年 
JST資料番号： U1100A  ISSN： 2055-0294  資料種別： 逐次刊行物 (A)
記事区分： 短報  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： ベバシズマブ(BEV)は蛋白尿と腎損傷をもたらす。腎移植後の...

シソーラス用語： *腎臓移植 ,...
準シソーラス用語： *結腸直腸癌 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0598132&from=J-GLOBAL&jstjournalNo=U1100A") }}

著者キーワード (6件)： 腎移植 ,  タクロリムス ,  ベバシズマブ ,  蛋白尿 ,  副作用 ,  大腸癌

分類 (3件)： 消化器の腫よう  (GH04000D) ,  腫ようの薬物療法  (GE03032C) ,  抗腫よう薬の臨床への応用  (GW16020L)

物質索引 (4件)： タクロリムス ,  ミコフェノール酸モフェチル ,  5-フルオロウラシル ,  レボホリナート

引用文献 (24件)：

• N Engl J Med; Strategies to improve long-term outcomes after renal transplantation; M Pascual, T Theruvath, T Kawai, N Tolkoff-Rubin, AB Cosimi; 346; 2002; 580-590; 10.1056/NEJMra011295; citation_id=CR1
• Nephrol Dial Transplant; Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study; JM Morales, R Marcén, D Castillo, A Andres, M Gonzalez-Molina, F Oppenheimer; 27; Suppl 4; 2012; iv39-iv46; 10.1093/ndt/gfs544; citation_id=CR2
• Yonsei Med; Clinical characteristics and treatment outcomes of colorectal cancer in renal transplant recipients in Korea; JY Kim, MK Ju, MS Kim, NK Kim, SK Sohn, SI Kim; 52; 2011; 454-462; 10.3349/ymj.2011.52.3.454; citation_id=CR3
• J Clin Oncol; Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis; DJ Hicklin, LM Ellis; 23; 2005; 1011-1027; 10.1200/JCO.2005.06.081; citation_id=CR4
• J Clin Oncol; Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study; LB Saltz, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong; 26; 2008; 2013-2019; 10.1200/JCO.2007.14.9930; citation_id=CR5

タイトルに関連する用語 (7件)： 腎移植 ,  結腸直腸癌 ,  患者 ,  ベバシズマブ ,  投与 ,  蛋白尿 ,  症例報告